177 related articles for article (PubMed ID: 32612000)
1. Discovery of a Novel Class of State-Dependent Na
Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
[TBL] [Abstract][Full Text] [Related]
2. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
3. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
[TBL] [Abstract][Full Text] [Related]
4. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Nav1.7 channel by a novel blocker QLS-81 for alleviation of neuropathic pain.
Niu HL; Liu YN; Xue DQ; Dong LY; Liu HJ; Wang J; Zheng YL; Zou AR; Shao LM; Wang K
Acta Pharmacol Sin; 2021 Aug; 42(8):1235-1247. PubMed ID: 34103689
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Potent, Selective, and State-Dependent Na
Ramdas V; Talwar R; Kanoje V; Loriya RM; Banerjee M; Patil P; Joshi AA; Datrange L; Das AK; Walke DS; Kalhapure V; Khan T; Gote G; Dhayagude U; Deshpande S; Shaikh J; Chaure G; Pal RR; Parkale S; Suravase S; Bhoskar S; Gupta RV; Kalia A; Yeshodharan R; Azhar M; Daler J; Mali V; Sharma G; Kishore A; Vyawahare R; Agarwal G; Pareek H; Budhe S; Nayak A; Warude D; Gupta PK; Joshi P; Joshi S; Darekar S; Pandey D; Wagh A; Nigade PB; Mehta M; Patil V; Modi D; Pawar S; Verma M; Singh M; Das S; Gundu J; Nemmani K; Bock MG; Sharma S; Bakhle D; Kamboj RK; Palle VP
J Med Chem; 2020 Jun; 63(11):6107-6133. PubMed ID: 32368909
[TBL] [Abstract][Full Text] [Related]
7. The discovery and optimization of benzimidazoles as selective Na
Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Sun S; Cohen CJ; Dehnhardt CM
Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
[TBL] [Abstract][Full Text] [Related]
9. Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.
Kamei T; Kudo T; Yamane H; Ishibashi F; Takada Y; Honda S; Maezawa Y; Ikeda K; Oyamada Y
Biochem Biophys Res Commun; 2024 Aug; 721():150126. PubMed ID: 38776832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
11. Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.
Cardoso FC; Dekan Z; Smith JJ; Deuis JR; Vetter I; Herzig V; Alewood PF; King GF; Lewis RJ
Br J Pharmacol; 2017 Aug; 174(15):2528-2544. PubMed ID: 28542706
[TBL] [Abstract][Full Text] [Related]
12. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
Payandeh J; Hackos DH
Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
[TBL] [Abstract][Full Text] [Related]
15. Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
Sun S; Jia Q; Zenova AY; Wilson MS; Chowdhury S; Focken T; Li J; Decker S; Grimwood ME; Andrez JC; Hemeon I; Sheng T; Chen CA; White A; Hackos DH; Deng L; Bankar G; Khakh K; Chang E; Kwan R; Lin S; Nelkenbrecher K; Sellers BD; DiPasquale AG; Chang J; Pang J; Sojo L; Lindgren A; Waldbrook M; Xie Z; Young C; Johnson JP; Robinette CL; Cohen CJ; Safina BS; Sutherlin DP; Ortwine DF; Dehnhardt CM
J Med Chem; 2019 Jan; 62(2):908-927. PubMed ID: 30499663
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na
Luo G; Chen L; Easton A; Newton A; Bourin C; Shields E; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Sivarao DV; Senapati A; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
J Med Chem; 2019 Jan; 62(2):831-856. PubMed ID: 30576602
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided Discovery of a New Nav1.7 Inhibitor for Treatment of Pain and Itch.
Chandra S; Wang Z; Tao X; Chen O; Luo X; Ji RR; Bortsov AV
Anesthesiology; 2020 Sep; 133(3):611-627. PubMed ID: 32788559
[TBL] [Abstract][Full Text] [Related]
18. New aryl and acylsulfonamides as state-dependent inhibitors of Na
Zidar N; Tomašič T; Kikelj D; Durcik M; Tytgat J; Peigneur S; Rogers M; Haworth A; Kirby RW
Eur J Med Chem; 2023 Oct; 258():115530. PubMed ID: 37329714
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a biarylamide series of potent, state-dependent Na
Schenkel LB; DiMauro EF; Nguyen HN; Chakka N; Du B; Foti RS; Guzman-Perez A; Jarosh M; La DS; Ligutti J; Milgram BC; Moyer BD; Peterson EA; Roberts J; Yu VL; Weiss MM
Bioorg Med Chem Lett; 2017 Aug; 27(16):3817-3824. PubMed ID: 28684121
[TBL] [Abstract][Full Text] [Related]
20. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]